Determinants of antepartum human immunodeficiency virus testing in a non-medicaid obstetric population

Infectious Diseases in Obstetrics and Gynecology

Volumn 6, Issue 5, 1998, Pages 209-213

  Cardonick, E ^a,b   Daly, S ^a   Dooley, M ^a   Elles, K ^a   Silverman, N S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Dept of Obstetrics and Gynecology ^*  (United States)

Author keywords

HIV screening; Pregnancy; Risk factors; Sexually transmitted disease

Indexed keywords

ADULT; CONFERENCE PAPER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; PATIENT COUNSELING; PREGNANCY; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; VIRUS INFECTION; VIRUS TRANSMISSION;

BLOOD TRANSFUSION; DEMOGRAPHY; DISEASE TRANSMISSION, VERTICAL; FEMALE; FORECASTING; HIV INFECTIONS; HUMANS; MARITAL STATUS; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SOCIAL CLASS;

EID: 0032423733     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-0997(1998)6:5<209::AID-IDOG4>3.0.CO;2-J     Document Type: Conference Paper

References (14)

1. Gupta G: Human immunodeficiency virus testing and counseling: nuts and bolts. Am J Obstet Gynecol 175:6: 1502-1510, 1996.
2. Ecker J: The cost-effectiveness of human immunodeficiency virus screening in pregnancy. Am J Obstet Gynecol 174:716-720, 1996.
3. Centers for Disease Control: HIV testing among women ages 18-44 years-United States, 1991 and 1993. Morb Mortal Wkly Rep 45:733-737, 1996.
4. Centers for Disease Control: Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. Morb Mortal Wkly Rep 43:1-20, 1994.
5. Connor EM, Sperling RS, Gerber R, et al: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 331:1173-1180, 1994.
6. Silverman NS, Rohner D, Turner B: Attitudes toward health care, HIV infection and perinatal transmission interventions in a cohort of inner-city, pregnant women. Am J Perinatol 14:341-346, 1997.
7. Centers for Disease Control: AIDS among children - United States, 1996. Morb Mortal Wkly Rep 43:1005-1010, 1996.
8. Irwin K, Valdiserri RO, Holmberg SD: The acceptability of voluntary HIV antibody testing in the United States: A decade of lessons learned. AIDS 10:1707-1717, 1996.
9. Landesman S, Minkoff H, Holman S, McCalla S, Sijin O: Serosurvey of human immunodeficiency virus infection in parturients. JAMA 258;2701-2703, 1987.
10. Barbacci M, Repke, JT, Chaisson RE: Routine prenatal screening for HIV infection. Lancet 337:709-711, 1991.
11. Segal A: Physician attitudes toward human immunodeficiency virus testing in pregnancy. Am J Obstet Gynecol 174:1750-1756, 1996.
12. Sperling R, Sacks S, Mayer L, Joyner M, Berkowitz RL: Umbilical cord blood serosurvey for human immunodeficiency virus in parturient women in a voluntary hospital in New York City. Obstet Gynecol 73:179-181, 1989.
13. Silverman NS, Weiner SM: Increased HIV testing with an on-site prenatal clinic counselor. J Matern Fetal Med 2:209-213, 1993.
14. Lindsay MK, Peterson HB, Willis S, Slade BA, Gramling J, Williams H, Klein L: Incidence and prevalence of human immunodeficiency virus infection in a prenatal population undergoing routine voluntary human immunodeficiency virus screening, July 1987-June 1990. Am J Obstet Gynecol 165:961-964, 1991.